Dr. Emil Lou, Intima Bioscience Principal Investigator, Named to 2026 TIME100 Health List
PR Newswire —
Dr. Lou is honored alongside Emma Weston-Dimery, his patient, underscoring Intima's impact on global health NEW YORK and CAMBRIDGE, England, Feb. 11, 2026 /PRNewswire/ -- Intima Bioscience, a clinical stage oncology company focused on curative intent in solid tumor cancer, today announced...